Skip to content
value.today

Quest Diagnostics Incorporated: peers

Change the peers

Quest Diagnostics Incorporated beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.

Side by side#

Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.

Quest Diagnostics Incorporated, Labcorp Holdings Inc., DexCom, Inc., Guardant Health, Inc., Mettler-Toledo International Inc., Illumina, Inc., Medpace Holdings, Inc., IDEXX Laboratories, Inc. side by side: each figure with its period and source, its rank among these companies and its percentile in the company's sector and country
MeasureQuest Diagnostics Incorporatedbase
DGX · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Labcorp Holdings Inc.
LH · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
DexCom, Inc.
DXCM · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Guardant Health, Inc.
GH · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Mettler-Toledo International Inc.
MTD · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Illumina, Inc.
ILMN · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Medpace Holdings, Inc.
MEDP · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
IDEXX Laboratories, Inc.
IDXX · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Group median
Size
Market cap (Better neither way: ranked highest first)$27.8 BOct 30, 2026 · Market data5th of 8$26.3 BOct 22, 2026 · Market data6th of 8$29.9 BOct 22, 2026 · Market data4th of 8$24.1 BOct 28, 2026 · Market data7th of 8$32.5 BOct 21, 2026 · Market data3rd of 8$40.7 BOct 26, 2026 · Market data2nd of 8$19.0 BOct 30, 2026 · Market data8th of 8$41.5 BOct 6, 2026 · Market data1st of 8$28.9 B8 ranked
Revenue (Better neither way: ranked highest first)$11.0 BFY2025 · SEC2nd of 8$14.0 BFY2025 · SEC1st of 8$4.7 BFY2025 · SEC3rd of 8$982 MFY2025 · SEC8th of 8$4.0 BFY2025 · SEC6th of 8$4.3 BFY2025 · SEC4th of 8$2.5 BFY2025 · SEC7th of 8$4.3 BFY2025 · SEC5th of 8$4.3 B8 ranked
Net income (Higher is better)$992 MFY2025 · SEC2nd of 8$877 MFY2025 · SEC3rd of 8$836 MFY2025 · SEC6th of 8$-416 MFY2025 · SEC8th of 8$869 MFY2025 · SEC4th of 8$850 MFY2025 · SEC5th of 8$451 MFY2025 · SEC7th of 8$1.1 BFY2025 · SEC1st of 8$860 M8 ranked
Employees (Better neither way: ranked highest first)57,000December 31, 2025 · Profile2nd of 880,000As on 2022 · Profile1st of 811,100December 31, 2025 · Profile3rd of 82,506December 31, 2025 · Profile7th of 81,600December 31, 2025 · Profile8th of 810,200As on Jan-2023 · Profile5th of 86,200December 31, 2025 · Profile6th of 810,780As on 2022 · Profile4th of 810,4908 ranked
Growth
Revenue growth (Higher is better)+11.8%FY2025 · SEC4th of 854th65th+7.3%FY2025 · SEC6th of 843rd53rd+15.6%FY2025 · SEC3rd of 860th72nd+32.9%FY2025 · SEC1st of 879th87th+4.0%FY2025 · SEC7th of 834th42nd-0.7%FY2025 · SEC8th of 824th27th+20.0%FY2025 · SEC2nd of 868th79th+10.4%FY2025 · SEC5th of 851st63rd+11.1%8 ranked
Revenue growth, 3 years a year (Higher is better)+3.7%FY2025 · SEC6th of 838th48th+5.5%FY2025 · SEC5th of 843rd55th+17.0%FY2025 · SEC3rd of 868th82nd+29.8%FY2025 · SEC1st of 881st92nd+0.9%FY2025 · SEC7th of 829th36th-1.8%FY2025 · SEC8th of 822nd26th+20.1%FY2025 · SEC2nd of 872nd85th+8.5%FY2025 · SEC4th of 850th65th+7.0%8 ranked
Earnings per share growth (Higher is better)+13.8%FY2025 · SEC5th of 655th56th+18.3%FY2025 · SEC4th of 661st61st+47.2%FY2025 · SEC1st of 675th80th————+3.9%FY2025 · SEC6th of 642nd43rd————+21.0%FY2025 · SEC3rd of 663rd64th+22.6%FY2025 · SEC2nd of 665th65th+19.7%6 ranked
Margins and returns
Gross margin (Higher is better)33.2%FY2025 · SEC6th of 719th40th28.8%FY2025 · SEC7th of 715th33rd60.1%FY2025 · SEC4th of 753rd74th64.5%FY2025 · SEC2nd of 759th78th59.4%FY2025 · SEC5th of 752nd73rd66.1%FY2025 · SEC1st of 762nd79th————61.8%FY2025 · SEC3rd of 755th76th60.1%7 ranked
Operating margin (Higher is better)14.1%FY2025 · SEC5th of 781st77th9.9%FY2025 · SEC6th of 773rd68th19.6%FY2025 · SEC3rd of 788th85th-44.5%FY2025 · SEC7th of 733rd16th————18.6%FY2025 · SEC4th of 787th84th21.1%FY2025 · SEC2nd of 789th87th31.6%FY2025 · SEC1st of 795th94th18.6%7 ranked
Net margin (Higher is better)9.0%FY2025 · SEC6th of 878th72nd6.3%FY2025 · SEC7th of 872nd65th17.9%FY2025 · SEC4th of 889th87th-42.4%FY2025 · SEC8th of 832nd16th21.6%FY2025 · SEC2nd of 891st91st19.6%FY2025 · SEC3rd of 889th89th17.8%FY2025 · SEC5th of 888th87th24.6%FY2025 · SEC1st of 892nd92nd17.9%8 ranked
Free cash flow margin (Higher is better)12.3%FY2025 · SEC6th of 875th75th8.6%FY2025 · SEC7th of 869th66th23.1%FY2025 · SEC3rd of 892nd91st-23.7%FY2025 · SEC8th of 836th16th21.1%FY2025 · SEC5th of 889th89th21.4%FY2025 · SEC4th of 890th89th26.9%FY2025 · SEC1st of 895th94th24.6%FY2025 · SEC2nd of 893rd93rd21.3%8 ranked
Return on equity (Higher is better)14.2%FY2025 · SEC5th of 686th76th10.5%FY2025 · SEC6th of 681st66th34.5%FY2025 · SEC3rd of 695th93rd————————33.4%FY2025 · SEC4th of 695th93rd70.2%FY2025 · SEC1st of 698th97th66.2%FY2025 · SEC2nd of 698th97th33.9%6 ranked
Return on invested capital (Higher is better)9.5%FY2025 · SEC2nd of 241st44th————————————————————————57.3%FY2025 · SEC1st of 298th97th33.4%2 ranked
Valuation
P/E ratio (Better neither way: ranked highest first)24.6×price Oct 30, 2026 · Market data7th of 743rd63rd26.2×price Oct 22, 2026 · Market data6th of 745th66th30.2×price Oct 22, 2026 · Market data5th of 751st72nd————34.8×price Oct 21, 2026 · Market data4th of 754th77th45.5×price Oct 26, 2026 · Market data1st of 769th85th36.6×price Oct 30, 2026 · Market data2nd of 758th79th35.1×price Oct 6, 2026 · Market data3rd of 755th78th34.8×7 ranked
Price to sales (Better neither way: ranked highest first)2.4×price Oct 30, 2026 · Market data7th of 838th52nd1.8×price Oct 22, 2026 · Market data8th of 831st45th5.9×price Oct 22, 2026 · Market data6th of 861st80th18.8×price Oct 28, 2026 · Market data1st of 882nd94th7.7×price Oct 21, 2026 · Market data4th of 867th86th9.0×price Oct 26, 2026 · Market data2nd of 872nd88th6.7×price Oct 30, 2026 · Market data5th of 864th83rd8.9×price Oct 6, 2026 · Market data3rd of 871st88th7.2×8 ranked
Price to book (Better neither way: ranked highest first)3.9×price Oct 30, 2026 · Market data5th of 659th70th3.0×price Oct 22, 2026 · Market data6th of 650th62nd10.9×price Oct 22, 2026 · Market data4th of 685th90th————————15.0×price Oct 26, 2026 · Market data3rd of 690th94th41.3×price Oct 30, 2026 · Market data1st of 697th98th25.9×price Oct 6, 2026 · Market data2nd of 694th97th12.9×6 ranked
Free cash flow yield (Higher is better)4.9%price Oct 30, 2026 · Market data1st of 887th66th4.6%price Oct 22, 2026 · Market data2nd of 885th64th3.6%price Oct 22, 2026 · Market data3rd of 881st57th-1.0%price Oct 28, 2026 · Market data8th of 865th35th2.6%price Oct 21, 2026 · Market data5th of 878th50th2.3%price Oct 26, 2026 · Market data7th of 876th48th3.6%price Oct 30, 2026 · Market data3rd of 881st57th2.5%price Oct 6, 2026 · Market data6th of 877th50th3.1%8 ranked
Financial strength
Debt to equity (Lower is better)0.8×FY2025 · SEC3rd of 369th60th0.6×FY2025 · SEC2nd of 359th49th————————————————————0.3×FY2025 · SEC1st of 338th29th0.6×3 ranked
Net debt to EBITDA (Lower is better)2.5×FY2025 · SEC3rd of 361st56th2.2×FY2025 · SEC2nd of 354th52nd————————————————————0.2×FY2025 · SEC1st of 330th21st2.2×3 ranked
Interest cover (Higher is better)————6.2×FY2025 · SEC2nd of 387th77th63.8×FY2025 · SEC1st of 399th97th-112.1×FY2025 · SEC3rd of 313th6th————————————————6.2×3 ranked
Piotroski F-score (Higher is better)8 of 9FY2025 · SEC1st of 58 of 9FY2025 · SEC1st of 5——5 of 9FY2025 · SEC4th of 55 of 9FY2025 · SEC4th of 5————8 of 9FY2025 · SEC1st of 58.0 of 95 ranked
Scorecard
Scorecard (Higher is better)18 of 29FY2025 · Scorecard5th of 820 of 28FY2025 · Scorecard3rd of 818 of 24FY2025 · Scorecard1st of 87 of 22FY2025 · Scorecard8th of 811 of 19FY2025 · Scorecard6th of 811 of 23FY2025 · Scorecard7th of 816 of 23FY2025 · Scorecard4th of 819 of 26FY2025 · Scorecard2nd of 866% passed8 ranked
Valuation checks (Higher is better)2 of 6FY2025 · Scorecard2nd of 83 of 6FY2025 · Scorecard1st of 81 of 6FY2025 · Scorecard3rd of 80 of 5FY2025 · Scorecard7th of 81 of 6FY2025 · Scorecard3rd of 80 of 6FY2025 · Scorecard7th of 81 of 6FY2025 · Scorecard3rd of 81 of 6FY2025 · Scorecard3rd of 817% passed8 ranked
Growth checks (Higher is better)3 of 6FY2025 · Scorecard7th of 84 of 6FY2025 · Scorecard4th of 86 of 6FY2025 · Scorecard1st of 84 of 6FY2025 · Scorecard4th of 84 of 6FY2025 · Scorecard4th of 82 of 6FY2025 · Scorecard8th of 86 of 6FY2025 · Scorecard1st of 86 of 6FY2025 · Scorecard1st of 867% passed8 ranked
Profitability checks (Higher is better)3 of 6FY2025 · Scorecard7th of 83 of 5FY2025 · Scorecard6th of 85 of 5FY2025 · Scorecard1st of 81 of 4FY2025 · Scorecard8th of 82 of 2FY2025 · Scorecard1st of 84 of 5FY2025 · Scorecard5th of 85 of 5FY2025 · Scorecard1st of 86 of 6FY2025 · Scorecard1st of 890% passed8 ranked
Financial health checks (Higher is better)5 of 5FY2025 · Scorecard1st of 86 of 6FY2025 · Scorecard1st of 84 of 4FY2025 · Scorecard1st of 82 of 4FY2025 · Scorecard8th of 82 of 2FY2025 · Scorecard1st of 83 of 3FY2025 · Scorecard1st of 82 of 3FY2025 · Scorecard7th of 85 of 5FY2025 · Scorecard1st of 8100% passed8 ranked
Shareholder returns checks (Higher is better)5 of 6FY2025 · Scorecard1st of 84 of 5FY2025 · Scorecard2nd of 82 of 3FY2025 · Scorecard3rd of 80 of 3FY2025 · Scorecard8th of 82 of 3FY2025 · Scorecard3rd of 82 of 3FY2025 · Scorecard3rd of 82 of 3FY2025 · Scorecard3rd of 81 of 3FY2025 · Scorecard7th of 867% passed8 ranked
Ownership
Held by institutions (Better neither way: ranked highest first)93.3%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in6th of 895.0%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in5th of 898.2%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in4th of 898.2%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in3rd of 8100.2%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 8106.3%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 882.5%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in8th of 893.1%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in7th of 896.6%8 ranked
Institutions holding (Better neither way: ranked highest first)1,1392026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 81,0802026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in4th of 81,0542026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in5th of 86732026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in8th of 88432026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in6th of 81,1112026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in3rd of 87592026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in7th of 81,2782026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 81,0678 ranked
Institutional holding, change over the quarter (Better neither way: ranked highest first)+2.9 pp2026-Q2 against 2026-Q1 · 13F6th of 8+3.0 pp2026-Q2 against 2026-Q1 · 13F5th of 8+8.2 pp2026-Q2 against 2026-Q1 · 13F1st of 8-3.8 pp2026-Q2 against 2026-Q1 · 13F8th of 8+4.2 pp2026-Q2 against 2026-Q1 · 13F3rd of 8+0.5 pp2026-Q2 against 2026-Q1 · 13F7th of 8+4.3 pp2026-Q2 against 2026-Q1 · 13F2nd of 8+3.9 pp2026-Q2 against 2026-Q1 · 13F4th of 8+3.4 pp8 ranked
Dividends
Dividend yield (Higher is better)1.3%FY2025 · SEC1st of 261st33rd0.9%FY2025 · SEC2nd of 248th24th————————————————————————1.1%2 ranked
Shareholder yield (Higher is better)2.9%FY2025 · SEC3rd of 858th47th2.6%FY2025 · SEC4th of 855th43rd1.7%FY2025 · SEC7th of 843rd30th0.2%FY2025 · SEC8th of 818th10th2.5%FY2025 · SEC5th of 852nd40th1.8%FY2025 · SEC6th of 845th31st4.8%FY2025 · SEC1st of 876th67th2.9%FY2025 · SEC2nd of 860th47th2.5%8 ranked
Dividend payout (Better neither way: ranked highest first)35.6%FY2025 · SEC1st of 265th48th27.5%FY2025 · SEC2nd of 251st35th————————————————————————31.5%2 ranked
Dividend per share (Better neither way: ranked highest first)——$2.88FY2025 · SEConly one with it————————————$2.88—
Years of dividend raises (Higher is better)15to 2025 · SEConly one with it——————————————15—

Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).

Key: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = Quest Diagnostics Incorporated: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Labcorp Holdings Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; DexCom, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Guardant Health, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Mettler-Toledo International Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Illumina, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; Medpace Holdings, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover; IDEXX Laboratories, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover.

Where each stands in its sector and country: Operating margin#

The dot is the company; the line runs from the 10th to the 90th percentile of all the companies of its sector (or country) with the figure, the box holds the middle half and the tick is the median. Each company's newest fiscal year; figures that divide by the market value only with a market cap at most 60 days old. How percentiles are worked out.

Operating margin: each company's figure and its percentile in its sector and its country
CompanyOperating marginIn its sectorIn its country
Quest Diagnostics Incorporated14.1%FY2025
81st percentile in Healthcaremedian -7.7%, 674 companies
77th percentile in USAmedian 3.5%, 2,595 companies
Labcorp Holdings Inc.9.9%FY2025
73rd percentile in Healthcaremedian -7.7%, 674 companies
68th percentile in USAmedian 3.5%, 2,595 companies
DexCom, Inc.19.6%FY2025
88th percentile in Healthcaremedian -7.7%, 674 companies
85th percentile in USAmedian 3.5%, 2,595 companies
Guardant Health, Inc.-44.5%FY2025
33rd percentile in Healthcaremedian -7.7%, 674 companies
16th percentile in USAmedian 3.5%, 2,595 companies
Mettler-Toledo International Inc.———
Illumina, Inc.18.6%FY2025
87th percentile in Healthcaremedian -7.7%, 674 companies
84th percentile in USAmedian 3.5%, 2,595 companies
Medpace Holdings, Inc.21.1%FY2025
89th percentile in Healthcaremedian -7.7%, 674 companies
87th percentile in USAmedian 3.5%, 2,595 companies
IDEXX Laboratories, Inc.31.6%FY2025
95th percentile in Healthcaremedian -7.7%, 674 companies
94th percentile in USAmedian 3.5%, 2,595 companies

Revenue by fiscal year, and the rank in the group#

Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).

Revenue

$0 M$3.5 B$7.0 B$10.5 B$14.0 B200820102012201420162018202020222024Quest Diagnostics Incorporated $11.0 BLabcorp Holdings Inc. $14.0 BDexCom, Inc. $4.7 BGuardant Health, Inc. $982 MMettler-Toledo International Inc. $4.0 BIllumina, Inc. $4.3 BMedpace Holdings, Inc. $2.5 BIDEXX Laboratories, Inc. $4.3 B

Rank in the group

1st2nd3rd4th5th6th7th8th201120122013201420152016201720182019202020212022202320242025Quest Diagnostics Incorporated: 1st of 6 in 2011Quest Diagnostics Incorporated: 1st of 6 in 2012Quest Diagnostics Incorporated: 1st of 6 in 2013Quest Diagnostics Incorporated: 1st of 6 in 2014Quest Diagnostics Incorporated: 2nd of 7 in 2015Quest Diagnostics Incorporated: 2nd of 8 in 2016Quest Diagnostics Incorporated: 2nd of 8 in 2017Quest Diagnostics Incorporated: 2nd of 8 in 2018Quest Diagnostics Incorporated: 2nd of 8 in 2019Quest Diagnostics Incorporated: 2nd of 8 in 2020Quest Diagnostics Incorporated: 2nd of 8 in 2021Quest Diagnostics Incorporated: 2nd of 8 in 2022Quest Diagnostics Incorporated: 2nd of 8 in 2023Quest Diagnostics Incorporated: 2nd of 8 in 2024Quest Diagnostics Incorporated: 2nd of 8 in 2025Quest Diagnostics IncorporLabcorp Holdings Inc.: 2nd of 6 in 2011Labcorp Holdings Inc.: 2nd of 6 in 2012Labcorp Holdings Inc.: 2nd of 6 in 2013Labcorp Holdings Inc.: 2nd of 6 in 2014Labcorp Holdings Inc.: 1st of 7 in 2015Labcorp Holdings Inc.: 1st of 8 in 2016Labcorp Holdings Inc.: 1st of 8 in 2017Labcorp Holdings Inc.: 1st of 8 in 2018Labcorp Holdings Inc.: 1st of 8 in 2019Labcorp Holdings Inc.: 1st of 8 in 2020Labcorp Holdings Inc.: 1st of 8 in 2021Labcorp Holdings Inc.: 1st of 8 in 2022Labcorp Holdings Inc.: 1st of 8 in 2023Labcorp Holdings Inc.: 1st of 8 in 2024Labcorp Holdings Inc.: 1st of 8 in 2025Labcorp Holdings Inc.DexCom, Inc.: 6th of 6 in 2011DexCom, Inc.: 6th of 6 in 2012DexCom, Inc.: 6th of 6 in 2013DexCom, Inc.: 6th of 6 in 2014DexCom, Inc.: 6th of 7 in 2015DexCom, Inc.: 6th of 8 in 2016DexCom, Inc.: 6th of 8 in 2017DexCom, Inc.: 6th of 8 in 2018DexCom, Inc.: 6th of 8 in 2019DexCom, Inc.: 6th of 8 in 2020DexCom, Inc.: 6th of 8 in 2021DexCom, Inc.: 6th of 8 in 2022DexCom, Inc.: 6th of 8 in 2023DexCom, Inc.: 4th of 8 in 2024DexCom, Inc.: 3rd of 8 in 2025DexCom, Inc.Guardant Health, Inc.: 8th of 8 in 2016Guardant Health, Inc.: 8th of 8 in 2017Guardant Health, Inc.: 8th of 8 in 2018Guardant Health, Inc.: 8th of 8 in 2019Guardant Health, Inc.: 8th of 8 in 2020Guardant Health, Inc.: 8th of 8 in 2021Guardant Health, Inc.: 8th of 8 in 2022Guardant Health, Inc.: 8th of 8 in 2023Guardant Health, Inc.: 8th of 8 in 2024Guardant Health, Inc.: 8th of 8 in 2025Guardant Health, Inc.Mettler-Toledo International Inc.: 3rd of 6 in 2011Mettler-Toledo International Inc.: 3rd of 6 in 2012Mettler-Toledo International Inc.: 3rd of 6 in 2013Mettler-Toledo International Inc.: 3rd of 6 in 2014Mettler-Toledo International Inc.: 3rd of 7 in 2015Mettler-Toledo International Inc.: 3rd of 8 in 2016Mettler-Toledo International Inc.: 4th of 8 in 2017Mettler-Toledo International Inc.: 4th of 8 in 2018Mettler-Toledo International Inc.: 4th of 8 in 2019Mettler-Toledo International Inc.: 4th of 8 in 2020Mettler-Toledo International Inc.: 4th of 8 in 2021Mettler-Toledo International Inc.: 4th of 8 in 2022Mettler-Toledo International Inc.: 4th of 8 in 2023Mettler-Toledo International Inc.: 6th of 8 in 2024Mettler-Toledo International Inc.: 6th of 8 in 2025Mettler-Toledo InternationIllumina, Inc.: 5th of 6 in 2011Illumina, Inc.: 5th of 6 in 2012Illumina, Inc.: 4th of 6 in 2013Illumina, Inc.: 4th of 6 in 2014Illumina, Inc.: 4th of 7 in 2015Illumina, Inc.: 4th of 8 in 2016Illumina, Inc.: 3rd of 8 in 2017Illumina, Inc.: 3rd of 8 in 2018Illumina, Inc.: 3rd of 8 in 2019Illumina, Inc.: 3rd of 8 in 2020Illumina, Inc.: 3rd of 8 in 2021Illumina, Inc.: 3rd of 8 in 2022Illumina, Inc.: 3rd of 8 in 2023Illumina, Inc.: 3rd of 8 in 2024Illumina, Inc.: 4th of 8 in 2025Illumina, Inc.Medpace Holdings, Inc.: 7th of 7 in 2015Medpace Holdings, Inc.: 7th of 8 in 2016Medpace Holdings, Inc.: 7th of 8 in 2017Medpace Holdings, Inc.: 7th of 8 in 2018Medpace Holdings, Inc.: 7th of 8 in 2019Medpace Holdings, Inc.: 7th of 8 in 2020Medpace Holdings, Inc.: 7th of 8 in 2021Medpace Holdings, Inc.: 7th of 8 in 2022Medpace Holdings, Inc.: 7th of 8 in 2023Medpace Holdings, Inc.: 7th of 8 in 2024Medpace Holdings, Inc.: 7th of 8 in 2025Medpace Holdings, Inc.IDEXX Laboratories, Inc.: 4th of 6 in 2011IDEXX Laboratories, Inc.: 4th of 6 in 2012IDEXX Laboratories, Inc.: 5th of 6 in 2013IDEXX Laboratories, Inc.: 5th of 6 in 2014IDEXX Laboratories, Inc.: 5th of 7 in 2015IDEXX Laboratories, Inc.: 5th of 8 in 2016IDEXX Laboratories, Inc.: 5th of 8 in 2017IDEXX Laboratories, Inc.: 5th of 8 in 2018IDEXX Laboratories, Inc.: 5th of 8 in 2019IDEXX Laboratories, Inc.: 5th of 8 in 2020IDEXX Laboratories, Inc.: 5th of 8 in 2021IDEXX Laboratories, Inc.: 5th of 8 in 2022IDEXX Laboratories, Inc.: 5th of 8 in 2023IDEXX Laboratories, Inc.: 5th of 8 in 2024IDEXX Laboratories, Inc.: 5th of 8 in 2025IDEXX Laboratories, Inc.
Revenue by fiscal year with each company's rank in the group and the source of each figure
Fiscal yearQuest Diagnostics IncorporatedLabcorp Holdings Inc.DexCom, Inc.Guardant Health, Inc.Mettler-Toledo International Inc.Illumina, Inc.Medpace Holdings, Inc.IDEXX Laboratories, Inc.
2025$11.0 BSEC2nd$14.0 BSEC1st$4.7 BSEC3rd$982 MSEC8th$4.0 BSEC6th$4.3 BSEC4th$2.5 BSEC7th$4.3 BSEC5th
2024$9.9 BSEC2nd$13.0 BSEC1st$4.0 BSEC4th$739 MSEC8th$3.9 BSEC6th$4.4 BSEC3rd$2.1 BSEC7th$3.9 BSEC5th
2023$9.3 BSEC2nd$12.2 BSEC1st$3.6 BSEC6th$564 MSEC8th$3.8 BSEC4th$4.5 BSEC3rd$1.9 BSEC7th$3.7 BSEC5th
2022$9.9 BSEC2nd$11.9 BSEC1st$2.9 BSEC6th$450 MSEC8th$3.9 BSEC4th$4.6 BSEC3rd$1.5 BSEC7th$3.4 BSEC5th
2021$10.8 BSEC2nd$13.1 BSEC1st$2.4 BSEC6th$374 MSEC8th$3.7 BSEC4th$4.5 BSEC3rd$1.1 BSEC7th$3.2 BSEC5th
2020$9.4 BSEC2nd$14.0 BSEC1st$1.9 BSEC6th$287 MSEC8th$3.1 BSEC4th$3.2 BSEC3rd$926 MSEC7th$2.7 BSEC5th
2019$7.7 BSEC2nd$11.6 BSEC1st$1.5 BSEC6th$214 MSEC8th$3.0 BSEC4th$3.5 BSEC3rd$861 MSEC7th$2.4 BSEC5th
2018$7.5 BSEC2nd$11.3 BSEC1st$1.0 BSEC6th$91 MSEC8th$2.9 BSEC4th$3.3 BSEC3rd$705 MSEC7th$2.2 BSEC5th
2017$7.4 BSEC2nd$10.3 BSEC1st$719 MSEC6th$50 MSEC8th$2.7 BSEC4th$2.8 BSEC3rd$436 MSEC7th$2.0 BSEC5th
2016$7.2 BSEC2nd$9.6 BSEC1st$573 MSEC6th$25 MSEC8th$2.5 BSEC3rd$2.4 BSEC4th$422 MSEC7th$1.8 BSEC5th
2015$7.5 BSEC2nd$8.7 BSEC1st$402 MSEC6th—$2.4 BSEC3rd$2.2 BSEC4th$359 MSEC7th$1.6 BSEC5th
2014$7.4 BSEC1st$6.0 BSEC2nd$259 MSEC6th—$2.5 BSEC3rd$1.9 BSEC4th—$1.5 BSEC5th

Key: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Ed. = The company's annual report, entered by value.today editors; WD = Wikidata, citing the annual report; Cap = value.today market caps (the last of each calendar year). The small ordinal is the rank in the group that year. Hover a figure for its fiscal year end.

Suggested peers of Quest Diagnostics Incorporated#

Companies of the same industry, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.

  • Labcorp Holdings Inc.LH · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $26.3 B market cap against $27.8 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $26.3 B (Oct 22, 2026) · revenue $14.0 B (year to December 2025)
    100 of 100 (industry or sector 50 + size 30 + country 15 + figures on file 5)
    In the group
  • DexCom, Inc.DXCM · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $29.9 B market cap against $27.8 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $29.9 B (Oct 22, 2026) · revenue $4.7 B (year to December 2025)
    100 of 100 (industry or sector 50 + size 30 + country 15 + figures on file 5)
    In the group
  • Guardant Health, Inc.GH · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $24.1 B market cap against $27.8 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $24.1 B (Oct 28, 2026) · revenue $982 M (year to December 2025)
    99 of 100 (industry or sector 50 + size 29 + country 15 + figures on file 5)
    In the group
  • Mettler-Toledo International Inc.MTD · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $32.5 B market cap against $27.8 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $32.5 B (Oct 21, 2026) · revenue $4.0 B (year to December 2025)
    99 of 100 (industry or sector 50 + size 29 + country 15 + figures on file 5)
    In the group
  • Illumina, Inc.ILMN · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $40.7 B market cap against $27.8 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $40.7 B (Oct 26, 2026) · revenue $4.3 B (year to December 2025)
    98 of 100 (industry or sector 50 + size 28 + country 15 + figures on file 5)
    In the group
  • Medpace Holdings, Inc.MEDP · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $19.0 B market cap against $27.8 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $19.0 B (Oct 30, 2026) · revenue $2.5 B (year to December 2025)
    98 of 100 (industry or sector 50 + size 28 + country 15 + figures on file 5)
    In the group
  • IDEXX Laboratories, Inc.IDXX · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $41.5 B market cap against $27.8 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $41.5 B (Oct 6, 2026) · revenue $4.3 B (year to December 2025)
    97 of 100 (industry or sector 50 + size 27 + country 15 + figures on file 5)
    In the group
  • Revvity, Inc.RVTY · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $17.6 B market cap against $27.8 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $17.6 B (Oct 23, 2026) · revenue $2.9 B (year to December 2025)
    97 of 100 (industry or sector 50 + size 27 + country 15 + figures on file 5)
    + Add
  • IQVIA Holdings Inc.IQV · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $45.1 B market cap against $27.8 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $45.1 B (Oct 27, 2026) · revenue $16.3 B (year to December 2025)
    97 of 100 (industry or sector 50 + size 27 + country 15 + figures on file 5)
    + Add
  • Waters CorporationWAT · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $44.8 B market cap against $27.8 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $44.8 B (Oct 27, 2026) · revenue $3.2 B (year to December 2025)
    97 of 100 (industry or sector 50 + size 27 + country 15 + figures on file 5)
    + Add
  • Charles River Laboratories International, Inc.CRL · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $17.2 B market cap against $27.8 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $17.2 B (Oct 28, 2026) · revenue $4.0 B (year to December 2025)
    97 of 100 (industry or sector 50 + size 27 + country 15 + figures on file 5)
    + Add
  • Agilent Technologies, Inc.A · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $48.8 B market cap against $27.8 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $48.8 B (Oct 19, 2026) · revenue $6.9 B (year to October 2025)
    96 of 100 (industry or sector 50 + size 26 + country 15 + figures on file 5)
    + Add

Any figure over the years, other peers or a saved group: open this group in the peer workspace.